Get the Stockscreener App
11.49
1.23%
0.14
Surrozen Inc stock is traded at $11.49, with a volume of 7,857.
It is up +1.23% in the last 24 hours and up +32.83% over the past month.
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), SZN-413 and SZN-043 (E3/ASGR1, SWEETS).
See More
Previous Close:
$11.35
Open:
$11.45
24h Volume:
7,857
Relative Volume:
0.51
Market Cap:
$98.47M
Revenue:
-
Net Income/Loss:
$-53.45M
P/E Ratio:
-0.5292
EPS:
-21.71
Net Cash Flow:
$-31.81M
1W Performance:
+3.14%
1M Performance:
+32.83%
6M Performance:
+2.59%
1Y Performance:
+45.63%
1-Day Range:
$11.27
$11.60
1-Week Range:
$10.11
$11.73
52-Week Range:
$5.90
$18.17
Surrozen Inc Stock (SRZN) Company Profile
Name
Surrozen Inc
Sector
Industry
Phone
650-475-2820
Address
171 OYSTER POINT BLVD, SOUTH SAN FRANCISCO
Compare SRZN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SRZN
Surrozen Inc
|
11.49 | 94.62M | 0 | -53.45M | -31.81M | -21.71 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Surrozen Inc Stock (SRZN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-30-25 | Initiated | H.C. Wainwright | Buy |
| Jan-03-25 | Upgrade | Guggenheim | Neutral → Buy |
| Oct-11-21 | Initiated | BofA Securities | Buy |
| Sep-15-21 | Initiated | Guggenheim | Buy |
| Sep-07-21 | Initiated | Stifel | Buy |
Surrozen Inc Stock (SRZN) Latest News
Does Surrozen Inc. fit your quant trading modelJuly 2025 Levels & Low Drawdown Momentum Ideas - Newser
Combining price and volume data for Surrozen Inc. Equity Warrant2025 Sector Review & Safe Entry Zone Tips - Newser
Should you wait for a breakout in Surrozen Inc.Market Trend Report & Capital Protection Trade Alerts - Newser
Developing predictive dashboards with Surrozen Inc. dataTrade Risk Assessment & Daily Technical Forecast Reports - Newser
Momentum Traders Eye Surrozen Inc. Equity Warrant for Quick BouncePortfolio Growth Summary & Low Risk High Win Rate Stock Picks - classian.co.kr
Chart based analysis of Surrozen Inc. Equity Warrant trends2025 Key Lessons & AI Driven Stock Price Forecasts - Newser
Quantitative breakdown of Surrozen Inc. recent movePortfolio Value Report & Free Accurate Trade Setup Notifications - Newser
What to do if you’re stuck in Surrozen Inc.Weekly Gains Summary & Daily Chart Pattern Signals - Newser
Volume spikes in Surrozen Inc. stock – what they meanJuly 2025 Recap & Safe Investment Capital Preservation Plans - Newser
Using data models to predict Surrozen Inc. Equity Warrant stock movement2025 Bull vs Bear & Stock Portfolio Risk Control - Newser
Is Surrozen Inc. Equity Warrant stock reversal real or fakeQuarterly Earnings Report & Long Hold Capital Preservation Plans - Newser
Surrozen Inc. stock chart pattern explainedWeekly Trade Review & Risk Managed Investment Entry Signals - Newser
Volatility clustering patterns for Surrozen Inc.2025 EndofYear Setup & Fast Entry High Yield Tips - Newser
Surrozen Inc. Equity Warrant stock volume spike explainedGDP Growth & Verified High Yield Trade Plans - Newser
Does Surrozen Inc. Equity Warrant fit your quant trading modelJuly 2025 Volume & Free Community Supported Trade Ideas - Newser
Advanced analytics toolkit walkthrough for Surrozen Inc.Stock Surge & Weekly Sector Rotation Insights - Newser
Is Surrozen Inc. Equity Warrant forming a bottoming baseJuly 2025 Spike Watch & High Return Trade Opportunity Guides - Newser
Has Surrozen Inc. found a price floorEarnings Summary Report & Capital Efficient Trading Techniques - Newser
How to escape a deep drawdown in Surrozen Inc. Equity Warrant2025 Top Gainers & Reliable Volume Spike Alerts - Newser
Surrozen Inc. Equity Warrant recovery potential after sell off2025 Market Outlook & Community Supported Trade Ideas - Newser
Using RSI to spot recovery in Surrozen Inc.New Guidance & Safe Entry Trade Reports - Newser
Institutional scanner results for Surrozen Inc.2025 Valuation Update & Weekly Breakout Watchlists - Newser
Real time breakdown of Surrozen Inc. stock performanceWatch List & Fast Gaining Stock Strategy Reports - Newser
Visual trend scoring systems applied to Surrozen Inc.Weekly Profit Report & Fast Moving Stock Watchlists - Newser
What indicators show strength in Surrozen Inc. Equity Warrant2025 Bull vs Bear & Weekly Breakout Watchlists - Newser
Sentiment analysis tools applied to Surrozen Inc. Equity WarrantMarket Risk Summary & Free Low Drawdown Momentum Trade Ideas - Newser
How to forecast Surrozen Inc. trends using time seriesPortfolio Value Summary & Verified Swing Trading Watchlist - Newser
Analyzing net buyer seller activity in Surrozen Inc. Equity WarrantGDP Growth & Pattern Based Trade Signal System - Newser
Does Surrozen Inc. show high probability of reboundGlobal Markets & Weekly Return Optimization Alerts - Newser
How to build a custom watchlist for Surrozen Inc.Weekly Investment Report & Free Reliable Trade Execution Plans - Newser
Surrozen Inc.’s volatility index tracking explainedDividend Hike & Safe Capital Growth Stock Tips - Newser
Surrozen Inc Stock (SRZN) Financials Data
Revenue
Net Income
Cash Flow
EPS
Surrozen Inc Stock (SRZN) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Li Yang | Exec. Vice President, Research |
Jan 03 '25 |
Sale |
17.37 |
843 |
14,643 |
13,345 |
| Williams Charles O | CFO and COO |
Jan 03 '25 |
Sale |
17.37 |
1,181 |
20,514 |
8,982 |
0.94%
1.72%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):